Document is current

Article History

Received: 10 May 2025

Accepted: 12 August 2025

First Online: 24 September 2025

Declarations

:

: The authors declare no competing interests.

: Taken together, this review has highlighted the essential constituents of flaxseed and their potential mechanisms in reducing fasting blood glucose levels, alleviating oxidative stress, balancing lipid profiles, and regulating inflammatory markers in individuals with diabetes. Flaxseed, whether consumed whole or in various processed forms, may serve as a complementary therapy alongside conventional antidiabetic medications.

: The authors declare that there is no financial or non-financial kind of interest.